Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

bioMerieux S.A. buy UBS Group AG

Start price
€103.80
24.08.24 / 50%
Target price
-
24.08.25
Performance (%)
4.72%
Price
€108.70
27.09.24
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 4.72%. This prediction currently runs until 24.08.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
bioMerieux S.A. 0.555% 0.555%
iShares Core DAX® 3.523% 3.763%
iShares Nasdaq 100 1.026% 2.380%
iShares Nikkei 225® -0.063% 0.000%
iShares S&P 500 0.557% 2.222%

Comments by UBS_Group_AG for this prediction

In the thread bioMerieux S.A. diskutieren

bioMérieux S.A. (OTCMKTS: BMXMF) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Ratings data for BMXMF provided by MarketBeat